Annual report pursuant to Section 13 and 15(d)

Consolidated Statements Of Cash Flows

v2.4.0.6
Consolidated Statements Of Cash Flows (USD $)
In Thousands, unless otherwise specified
 12 Months Ended
Jan. 31, 2012
Jan. 31, 2011
Jan. 31, 2010
Operating Activities      
Net loss $ (16,107) $ (1,764) $ (16,753)
Adjustments to reconcile net loss to net cash provided by (used in) operating activities:      
Depreciation and amortization 4,455 1,578 1,143
Loss on retirement of fixed assets 296 (15) 219
Stock-based compensation 9,187 1,612 477
Remeasurement of preferred stock warrants 4,499 869 239
Amortization of premium on investments 246    
Amortization of debt issuance cost and debt discount 190 4 2
Changes in assets and liabilities:      
Accounts receivable (24,526) (22,979) (14,873)
Prepaid expenses and other assets 676 (2,739) (1,955)
Accounts payable and accrued liabilities (865) 5,482 1
Accrued royalties 15,742 9,036 (2,235)
Accrued compensation 8,147 2,375 709
Deferred revenue 3,322 9,763 5,552
Reimbursement of cost of leasehold improvements 616    
Net cash provided by (used in) operating activities 5,878 3,222 (27,474)
Investing Activities      
Purchases of property and equipment (11,644) (8,211) (1,892)
Changes in restricted cash (520) 318 323
Purchases of short-term investments (66,890)    
Maturities of short-term investments 19,984    
Net cash used in investing activities (59,070) (7,893) (1,569)
Financing Activities      
Borrowings under debt arrangements   3,644 7,650
Repayments of debt (7,596) (392) (6,297)
Proceeds from issuance of common stock 2,074 548 122
Proceeds from issuance of common stock to directors for cash   3,800  
Proceeds from early exercise of stock options   1,705  
Proceeds from exercise of preferred stock warrants 165    
Proceeds from issuance of redeemable convertible preferred stock, net of issuance costs   22,206 34,124
Proceeds from initial public offering net of offering costs 90,632    
Payment of dividends to preferred stockholders at initial public offering (31,005)    
Proceeds from buyers in investor offer   7,908  
Payments to sellers in investor offer   (7,908)  
Excess tax benefit from stock-based compensation plans   44  
Net cash provided by financing activities 54,270 31,555 35,599
Net increase in cash and cash equivalents 1,078 26,884 6,556
Cash and cash equivalents at beginning of year 43,048 16,164 9,608
Cash and cash equivalents at end of year 44,126 43,048 16,164
Supplemental disclosures of noncash financing activities      
Conversion of preferred stock warrants into common stock warrants (2,151)    
Conversion of preferred stock into common stock (124,341)    
Issuance of preferred stock warrants     12
Issuance of Series B redeemable convertible preferred stock upon exercise of warrant   142  
Accruals of preferred stock dividends, net of reversals 25,218 (792) 6,461
Deemed dividend on Series D and Series E redeemable convertible preferred stock     1,443
Accretion of Preferred stock issuance cost 110 300 218
Supplemental disclosures of cash flow information      
Cash paid during the period for income taxes 125    
Cash paid during the period for interest $ 887 $ 371 $ 1,572